Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Completed · Phase 3
Conditions studied: Opioid-Induced Bowel Dysfunction
In brief
The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.
Key facts
- Study ID
- NCT00620061
- Run by
- Sucampo Pharma Americas, LLC
- People needed
- 439
- Starts
- 2007-12-01
- Expected to finish
- 2009-09-01
- Last updated by the study team
- 2020-01-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Has completed 12 weeks of blinded treatment in NCT00595946 or NCT00597428
- Will continue to be treated consistently for chronic, non-cancer-related pain with any full agonist opiate and will continue opiate therapy for the duration of the study
- Willing to continue to abstain from use of disallowed medications as defined per protocol
You may not qualify if…
- Has newly diagnosed impaired renal function identified at the Screening Visit [i.e., serum creatinine concentration > 1.8 milligrams per deciliter (mg/dL)]
- Has experienced an unexplained and/or clinically significant weight loss defined as > 5% within 90 days prior to Screening Visit.
- Has plans to participate in another trial with an investigational drug or device during the course of the extension study
Where it is running
- Simon Williamson Clinic, PC — Hueytown, Alabama, United States
- Alabama Orthopedic Clinic — Mobile, Alabama, United States
- Clinical Research Advantage, Inc./ Mesa Family Medical Center — Mesa, Arizona, United States
- Redpoint Research — Phoenix, Arizona, United States
- HOPE Research Institute — Phoenix, Arizona, United States
- Clinical Research Advantage, Inc. — Phoenix, Arizona, United States
- Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC — Tempe, Arizona, United States
- Clinical Research Advantage, Inc. — Tempe, Arizona, United States
- Premiere Pharamaceutical Research, LLC — Tempe, Arizona, United States
- Genova Clinical Research — Tucson, Arizona, United States
- Verona Clinical Research, Inc. — Tucson, Arizona, United States
- Advanced Clinical Therapeutics, LLC — Tucson, Arizona, United States
- Paradigm Clinical Research, Inc. — Tucson, Arizona, United States
- Quality of Life Medical & Research Center, LLC — Tucson, Arizona, United States
- Wilson and Charani — Tucson, Arizona, United States
- Arkansas Pain Research — Hot Springs, Arkansas, United States
- Teton Research, LLC — Little Rock, Arkansas, United States
- Advanced Clinical Research Institute — Anaheim, California, United States
- Orange County Clinical Trials — Anaheim, California, United States
- Advanced Pain Institute — Arcadia, California, United States
- Impact Clinical Trials — Beverly Hills, California, United States
- Digestive and Liver Disease Specialists — Garden Grove, California, United States
- RX Clinical Research, Inc. — Garden Grove, California, United States
- Loma Linda University — Loma Linda, California, United States
- The Birmingham Pain Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.